Over the past two decades, there has been a significant uptick in the topical use of insulin in corneal ulcer treatment, partly driven by the higher incidence of diabetes and ophthalmic surgeries (such as posterior segment vitrectomy) that can lead to the onset of neurotrophic keratopathy and subsequent severe corneal ulcers. This evidence concerns the gene INS and diabetes mellitus.